Rastislav Bahleda
6PUBLICATIONS
101CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 03, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.Francesco Facchinetti, Yohann Loriot, Floriane Brayé
|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.Petros Grivas, Elena Garralda, Funda Meric-Bernstam
|Apr 11, 2024
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.Benjamin Garmezy, Mitesh J Borad, Rastilav Bahleda
|Jun 29, 2023
Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma.Patrick Schöffski, Rastislav Bahleda, Andrew J Wagner
|Jun 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer.Francesco Facchinetti, Antoine Hollebecque, Floriane Braye
Pageof 1
Frequent Collaborators
2 joint publications
Ludovic Bigot
2 joint publications
Lambros Tselikas
2 joint publications
David Combarel
2 joint publications
Stefan Michiels
2 joint publications
Do-Youn Oh
2 joint publications
Damien Vasseur
2 joint publications
Floriane Braye
2 joint publications
Antoine Hollebecque
2 joint publications
James J Harding
2 joint publications
Francesco Facchinetti